One Shot, Long Life!
One Shot, Long Life!
Podcast Description
One shot, Long Life! is a podcast focused on The Global Health Advocacy Incubator's (GHAI) and its partner CSOs' Immunization Budget Advocacy program, aiming to boost advocacy for domestic funding and accountability to reach zero-dose children and improve immunization coverage across many low- and middle-income countries. Through conversational interviews, it seeks to elevate thought leadership and foster knowledge exchange among policymakers, donors, and health officials to strengthen immunization efforts in low- and middle-income countries.
Podcast Insights
Content Themes
The podcast concentrates on global health advocacy, immunization financing, and health equity, featuring topics like Nigeria's immunization financing gap, showcased in the first episode that discusses challenges faced by the country in securing domestic funding and innovative approaches to tackle these issues.
One shot, Long Life! is a podcast focused on The Global Health Advocacy Incubator’s (GHAI) and its partner CSOs’ Immunization Budget Advocacy program, aiming to boost advocacy for domestic funding and accountability to reach zero-dose children and improve immunization coverage across many low- and middle-income countries. Through conversational interviews, it seeks to elevate thought leadership and foster knowledge exchange among policymakers, donors, and health officials to strengthen immunization efforts in low- and middle-income countries.
Liberia needs about US$7.2 million for immunization next year, but its vaccine budget line has long sat near US$500,000. Under Gavi 6.0, the Government of Liberia now pays 60 percent of the cost of Gavi-supported vaccines.
On One Shot, Long Life!, host Abel Akara Ticha of the Global Health Advocacy Incubator (GHAI) talks with Hon. Julie Fatorma Wiah (chair, Joint Primary Health Care and Immunization Caucus), Emmanuel Tieh Delamy (GHAI country coordinator, Liberia) and Joyce Kilikpo (executive director, Public Health Initiative Liberia, or PHIL).
Quick FAQ
What is vaccine co-financing? Co-financing is the share of each Gavi-supported vaccine that a country buys from its own budget. Under Gavi's co-financing policy, that share rises with national income. Liberia paid its full 2025 share, about US$511,000, plus US$200,000 early toward 2026.
How is Liberia protecting immunization money? An Act of the Legislature created Liberia's immunization caucus. Section 10 of the draft Public Health Law would set up a statutory Immunization Trust Fund. “A law outlives any minister and creates a duty, not just a wish,” says Joyce Kilikpo of PHIL.
Why is spending the money the next test? A PHIL fiscal gap analysis found vaccine budget execution near 42 percent from 2020 to 2024. “Money on paper is not money in the clinic,” says GHAI's Emmanuel Tieh Delamy. Payment sign-offs have since dropped from 18 layers to five.
Also covered: PHIL scorecards that ended hidden vaccine fees in 42 facilities, higher tobacco taxes and County Development Fund support.
About ”One Shot, Long Life!”
One Shot, Long Life! is a podcast on immunization financing and vaccine advocacy in Africa and Asia. Host Abel Akara Ticha talks with parliamentarians, civil society leaders and health experts about how countries fund vaccines and keep children protected from preventable disease.
What is a zero-dose child? A zero-dose child has never received a single routine vaccine. Reaching these children is the front line of global immunization.
Why does domestic vaccine financing matter? As donor support tapers, national budgets cover a growing share of vaccine costs. Steady domestic funding keeps children protected year after year.
Follow the Global Health Advocacy Incubator on LinkedIn: https://www.linkedin.com/company/advocacyincubator/
Podcast home: https://www.advocacyincubator.org/one-shot-long-life
Listen and follow on Spotify, Apple Podcasts and your favorite podcast app.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.